Industry Data¶
1. Market Size¶
| Metric | Value |
|---|---|
| Global veterinary diagnostics market (2023) | ~$4.5 B |
| Projected (2030) | ~$8.5 B |
| CAGR | ~9–10% |
| POCT segment share | ~30% (fastest-growing) |
2. Technology Trends¶
| Trend | Impact |
|---|---|
| Shift from qualitative to quantitative POCT | FICT adoption |
| Instrument-read results | Reduced operator variability |
| Cloud-connected analyzers | Standard-curve sync, data management |
| Multi-analyte panels | Six-channel analyzers (FIA880) |
3. Regulatory Landscape¶
| Region | Framework | Key Requirements |
|---|---|---|
| EU | IVDR (Regulation 2017/746) | CE marking, performance evaluation |
| US | FDA (veterinary devices) | 510(k) or exempt |
| China | NMPA | Registration for IVD |
4. Key Growth Drivers¶
- Pet humanization — owners spend more on diagnostics
- Preventive care — early CKD/cardiac screening
- Same-visit results — client compliance and revenue capture
- Consolidation of reference labs — clinics keep testing in-house
For technology roadmap, see the research center.
Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.
Reviewed by: Migibio R&D Quality Committee
Last updated: 2026-08-13
Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.
Contact: Martin.Wong · Phone (WhatsApp): +86 13323237275 · Email: martinwang2024@gmail.com